STELARA (ustekinumab) Patient Assistance Program
Don’t let the high cost of brand specialty psoriasis/IBD biologics stand between you and the treatment you need. We help eligible patients access Stelara (ustekinumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Stelara (ustekinumab) is FDA-approved for moderate-to-severe plaque psoriasis (in adults and children 6 and older), active psoriatic arthritis, moderately to severely active Crohn's disease, and moderately to severely active ulcerative colitis. It is given as a subcutaneous injection (or an IV induction infusion for IBD).
- Without assistance, the average retail price for SC Stelara runs approximately $25,000–$28,000 per dose (90 mg), with maintenance dosing every 8 weeks for psoriasis and every 8 weeks for IBD.
- Through AffordMyPrescriptions, qualifying patients can access Stelara for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Multiple FDA-approved biosimilars to Stelara (Wezlana, Pyzchiva, Selarsdi, Steqeyma, Otulfi, Imuldosa, Yesintek) have launched in 2024–2026 at significantly lower cost.
What Is Stelara Prescription Assistance Program?
The Stelara Prescription Assistance Program is a manufacturer-sponsored initiative that provides Stelara at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for patients with psoriasis, psoriatic arthritis, Crohn’s, or ulcerative colitis who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, dermatology/rheumatology/gastroenterology coordination, TB screening, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your health, not paperwork.
Pharmacy Price Comparison
- Without assistance, brand Stelara costs roughly $25,000–$28,000 per dose. Multiple biosimilars are available at significantly lower cost. A Patient Assistance Program is the meaningful path for brand pricing — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Per dose (brand 90 mg SC) | ~$26,500.00 | Save ~$26,430/dose |
| Per dose (biosimilar) | ~$10,000+ | Save thousands/dose |
| Every 8 weeks maintenance | ~$13,250+/mo | Save ~$13,180+/mo |
| Annual cost (psoriasis) | ~$170,000+ | Save ~$169,000+/yr |
| IV induction (IBD) | ~$18,000+ | Save thousands |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Stelara Prescription Program?
The Patient Assistance Program is free to apply for and provides Stelara at no medication cost if approved. But the process involves detailed applications, prescriber coordination, TB screening documentation, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy. With multiple Stelara biosimilars now available at significantly lower cost, we’ll guide you to the most cost-effective path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Stelara:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $25,000–$28,000 per dose (brand) / lower for biosimilars per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Stelara assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Stelara Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Stelara:
Stelara (ustekinumab) is a biologic medicine in the IL-12/IL-23 inhibitor class used to treat moderate-to-severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn’s disease, and moderately to severely active ulcerative colitis. For psoriasis and PsA, it is given as a subcutaneous injection. For IBD, treatment starts with an IV induction infusion (weight-based) followed by SC maintenance every 8 weeks.
How Stelara Works:
Stelara targets the overactive immune signaling that drives plaque psoriasis, psoriatic arthritis, and inflammatory bowel disease. It specifically binds to the p40 subunit of the cytokines IL-12 and IL-23, blocking them from activating inflammatory T cells. By neutralizing these cytokines simultaneously, the medication dampens the immune response, leading to clearer skin, reduced joint pain, and improved intestinal health.
Form and use:
For skin and joint conditions, Stelara is administered as a subcutaneous injection at weeks 0 and 4, followed by maintenance doses every 12 weeks. In the case of IBD, treatment starts with a weight-based intravenous induction and continues with subcutaneous injections every 8 weeks. After receiving proper training, patients have the option to self-administer their maintenance injections at home.
Generic availability:
Between 2024 and 2026, multiple FDA-approved biosimilars for Stelara (ustekinumab) have launched in the U.S., including Wezlana and Pyzchiva. These biosimilars generally offer a more affordable alternative to the brand-name drug. Whether a patient receives the original Stelara or a biosimilar depends on their specific insurance coverage and the decision of their prescribing physician.
Warnings:
Stelara carries warnings for serious infections, such as the reactivation of latent tuberculosis, and requires TB screening before starting therapy. Other risks include malignancies, a rare brain condition called PRES, and severe hypersensitivity reactions. Additionally, patients should avoid receiving live vaccines while on this medication and must alert their team regarding potential embryo-fetal toxicity.
FAQ (Frequently Asked Questions)
How Much Does Stelara Cost Without Insurance?
Brand Stelara costs approximately $25,000–$28,000 per 90 mg dose. Annual costs commonly reach $170,000+. Biosimilars are typically 30–60% cheaper. Through AffordMyPrescriptions, qualifying patients receive Stelara at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Are Biosimilars To Stelara The Same Medicine?
Yes. The FDA-approved biosimilars to Stelara — Wezlana, Pyzchiva, Selarsdi, Steqeyma, Otulfi, Imuldosa, and Yesintek — are highly similar and clinically equivalent to brand Stelara. They contain the same active ingredient (ustekinumab) and produce the same clinical results. Wezlana carries an FDA interchangeability designation. We mention this directly because for many patients, a biosimilar at significantly lower cost is the right path.
How Is Stelara Given?
For psoriasis and PsA, Stelara is given as subcutaneous injection (45 mg or 90 mg based on weight) at Week 0, Week 4, then every 12 weeks thereafter. For IBD, treatment begins with a weight-based IV induction infusion followed by 90 mg SC every 8 weeks for maintenance. The injection can be self-administered at home after training.
Do I Need Tests Before Starting Stelara?
Yes. Patients are typically screened for tuberculosis (latent and active) before starting Stelara, since IL-12/23 inhibition can affect immune function. Your prescriber will also review your medical history, including any history of recurrent infections or vaccination needs.
Can I Get Stelara Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Stelara Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternatives — switching to a Stelara biosimilar at significantly lower cost, the manufacturer’s copay savings program if you have commercial insurance, independent foundations such as the National Psoriasis Foundation, Crohn’s & Colitis Foundation, PAN Foundation, or HealthWell Foundation, or asking your prescriber whether a different biologic on a more accessible assistance pathway would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Stelara, our team may be able to help you access assistance programs — or guide you to the cheaper biosimilar path if it is the better fit. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.